Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nina Bonkat"'
Autor:
Eva Fleischmann, Frederike Fellendorf, Elena M. Schönthaler, Melanie Lenger, Lena Hiendl, Nina Bonkat, Jolana Wagner-Skacel, Susanne Bengesser, Hans-Ferdinand Angel, Rüdiger J. Seitz, Eva Z. Reininghaus, Nina Dalkner
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundThe processes underlying believing have been labeled “creditions”, which are important brain functions between emotion and cognition. Creditions are influenced by both internal and external factors, one of which is the coronavirus disea
Externí odkaz:
https://doaj.org/article/9d36b6d25b10481792c4de188bc5984b
Autor:
Frederike T. Fellendorf, Nina Bonkat, Martina Platzer, Elena Schönthaler, Michaela Ratzenhofer, Susanne A. Bengesser, Nina Dalkner, Eva Z. Reininghaus
Publikováno v:
Vaccine: X, Vol 11, Iss , Pp 100186- (2022)
Background: Affective disorders such as major depressive disorder and bipolar disorder are associated with higher infection rates and a more severe course of coronavirus disease (COVID-19). In turn, COVID-19 could trigger mental disease relapse. Vacc
Externí odkaz:
https://doaj.org/article/50dc45033f0445128fd3ecb387f28b6f
Autor:
Nina Dalkner, Frederike T. Fellendorf, Nina Bonkat, Elena M.D. Schönthaler, Mirko Manchia, Dietmar Fuchs, Eva Z. Reininghaus
Publikováno v:
Current Topics in Medicinal Chemistry. 22:2107-2118
Background: Indoleamine 2,3-dioxygenase (IDO) activity is induced by cellular immune activation and therefore associated to inflammatory diseases, among others psychiatric disorders. This review aims to elucidate IDO activity reflected by kynurenine
Publikováno v:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 23(7)
People with severe mental illnesses (SMI: schizophrenia, depressive disorder, bipolar disorder) have a high risk of being infected by viruses and suffer a more severe infection illness course than the general population. The aim of this literature re
Autor:
Isabel Hodl, Ana González-Pinto, Rasmus Wentzer Licht, Nina Bonkat, Bruno Etain, Frederike T. Fellendorf, Jan Scott, Lars Vedel Kessing, Veerle Bergink, Marcella Rietschel, Trine Vik Lagerberg, Chantal Henry, Tomas Hajek, Mirko Manchia, Aysegul Yildiz, Ralph Kupka, Mikael Landén, Phillip Ritter, Nina Dalkner, Guy M. Goodwin, Eva Z. Reininghaus, Alessio Squassina, René Ernst Nieslen, Gunnar Morken, Andreas Reif, Eduard Vieta, Christoph U. Correll, Andreas Bechdolf, Michael Bauer, Mónica Martínez-Cengotitabengoa, Ole A. Andreassen, Andrea Fagiolini, Thomas G. Schulze
Publikováno v:
Addi. Archivo Digital para la Docencia y la Investigación
instname
European Neuropsychopharmacology
Reininghaus, E Z, Manchia, M, Dalkner, N, Bonkat, N, Squassina, A, Hodl, I, Vieta, E, Reif, A, Hajek, T, Landén, M, Correll, C U, Scott, J, Etain, B, Rietschel, M, Bergink, V, Martinez-Cengotitabengoa, M, Kessing, L V, Fagiolini, A, Bauer, M, Goodwin, G, Gonzalez-Pinto, A, Kupka, R W, Schulze, T G, Lagerberg, T V, Yildiz, A, Henry, C, Morken, G, Ritter, P, Nieslen, R E, Licht, R W, Bechdolf, A, Andreassen, O A & Fellendorf, F T 2022, ' Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic-a systematic review ', European Neuropsychopharmacology, vol. 54, pp. 90-99 . https://doi.org/10.1016/j.euroneuro.2021.09.001
European Neuropsychopharmacology, 2022, 54, pp.90-99. ⟨10.1016/j.euroneuro.2021.09.001⟩
instname
European Neuropsychopharmacology
Reininghaus, E Z, Manchia, M, Dalkner, N, Bonkat, N, Squassina, A, Hodl, I, Vieta, E, Reif, A, Hajek, T, Landén, M, Correll, C U, Scott, J, Etain, B, Rietschel, M, Bergink, V, Martinez-Cengotitabengoa, M, Kessing, L V, Fagiolini, A, Bauer, M, Goodwin, G, Gonzalez-Pinto, A, Kupka, R W, Schulze, T G, Lagerberg, T V, Yildiz, A, Henry, C, Morken, G, Ritter, P, Nieslen, R E, Licht, R W, Bechdolf, A, Andreassen, O A & Fellendorf, F T 2022, ' Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic-a systematic review ', European Neuropsychopharmacology, vol. 54, pp. 90-99 . https://doi.org/10.1016/j.euroneuro.2021.09.001
European Neuropsychopharmacology, 2022, 54, pp.90-99. ⟨10.1016/j.euroneuro.2021.09.001⟩
Bipolar disorder (BD) might be associated with higher infection rates of coronavirus disease (COVID-19) which in turn could result in worsening the clinical course and outcome. This may be due to a high prevalence of somatic comorbidities and an incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f359971aae139b464cee1385604f72
http://hdl.handle.net/11365/1175333
http://hdl.handle.net/11365/1175333
Autor:
Frederike T. Fellendorf, Nina Bonkat, Martina Platzer, Elena Schönthaler, Michaela Ratzenhofer, Susanne A. Bengesser, Nina Dalkner, Eva Z. Reininghaus
Publikováno v:
Vaccine: X. 11
Affective disorders such as major depressive disorder and bipolar disorder are associated with higher infection rates and a more severe course of coronavirus disease (COVID-19). In turn, COVID-19 could trigger mental disease relapse. Vaccinations lea